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WHAT THIS PAPER ADDS
 This article highlights the need to regard venous disease as a chronic illness, and evaluates its impact on quality of life and
importantly on depression an area which has not been tackled previously. The article emphasises the need for vascular surgeons to
look beyond the disease process and take a more holistic approach to patient care.a r t i c l e i n f o
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Objective: To evaluate the burden and impact of depression in patients with symptomatic varicose veins.
Methods: Patients with varicose veins referred to the vascular surgeons for further management, were
invited to complete a validated questionnaire relating to quality of life, using the Aberdeen Varicose
Veins Questionnaire (AVVQ), EuroQol-5D questionnaire (EQ-5D) and the EuroQol-Visual Analogue Score
(EQ-VAS); and depressive symptoms, using the Centre of Epidemiological Studies Depression Scale
(CES-D). Social, demographic, clinical (CEAP classiﬁcation, venous clinical severity score (VCSS)) and
venous disability score (VDS) data was also collected.
Results: One hundred patients, mean age 52.7 years (63 females; 37 males) were recruited. Twenty-nine
per cent of patients with varicose veins had depression scores suggestive of depression; no patient had
previously been diagnosed or was on treatment. Depression scores were not inﬂuenced by age (p ¼ 0.30)
or gender (p ¼ 0.60); and there was no correlation between depression scores and VCSS (p ¼ 0.07,
r2 ¼ 0.034), or between VDS groups 1, 2 or 3 (p¼ 0.75). There was a weak correlation between depression
scores and AVVQ (p ¼ 0.0009, r2 ¼ 0.12) and depression scores and EQ-5D (p < 0.0001, r2 ¼ 0.32) and
EQ-VAS (p < 0.0001, r2 ¼ 0.25).
Conclusion: Depression is prevalent in patients with symptomatic varicose veins, where it is commonly
undiagnosed and untreated. A more holistic approach to patients with venous disease is therefore
advocated.
 2012 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Introduction
Depression is a common mental health disorder, and affects
more than 120 million people worldwide.1 It is characterised by
symptoms of sadness, loss of interest or pleasure, feelings of guilt or
low self-worth, disturbed sleep or appetite, low energy and poor
concentration (WHO). These symptoms can become chronic or
recurrent impairing an individual’s ability to cope with daily life.
Depression costs the UK economy over £9 billion in lost workingx: þ44 203 311 7362.
vies).
ciety for Vascular Surgery. Publishdays, and although it can be both reliably diagnosed and treated in
a primary care setting only a quarter of patients with depression
seek medical advice or are receiving treatment.2
Overall, 1 in 10 adults in Britain suffer from depression at any
one time and depression is approximately 2e3 times more
common in patients with chronic physical health problems,
compared to those who have good physical health.3 This observa-
tion led to the development in 2009 of NICE guidelines in the UK,3
recommending that all adults, aged 18 years and older, with chronic
physical illness be screened for depression.
Varicose veins have been shown to impact on quality of life
(QoL),4 with increasing severity of disease having a proportionatelyed by Elsevier Ltd. All rights reserved.
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QoL.6 The effect of symptomatic varicose veins on mental health
outcomes and on depression speciﬁcally is less well deﬁned. The
aim of this study was to evaluate the burden of depression in
patients with symptomatic uncomplicated and complicated (asso-
ciated with skin changes which include eczema, lip-
odermatosclerosis and ulcers) varicose veins presenting to tertiary
care for treatment.7Methods
Patient selection
All patients referred by their General Practitioner (GP) to the
vascular surgery outpatients clinic at Charing Cross Hospital, Lon-
don, for management of their varicose veins, over a 6 month period
from January to June 2011, were invited to complete a validated
questionnaire relating to disease-speciﬁc quality of life, using the
Aberdeen Varicose Veins Questionnaire (AVVQ)8 and health-related
QoL, using the EuroQol-5D questionnaire (EQ-5D, EuroQol Group,
Rotterdam, The Netherlands) and EuroQol-Visual Analogue Score
(EQ-VAS).9 The presence of depressive symptoms was determined
using the Centre for Epidemiological Studies Depression Scale (CES-
D Scale)10 (see Table 1). A 20 item self-reporting scale which has
been shown to be both a sensitive and valid screening tool for
detecting depressive symptoms10 across different populations.11
No patients were excluded from the study. Ethics approval was
obtained from the Local Research Ethics Committee (LREC). Ques-
tionnaires were administered in a clinic setting following the
consultation and prior to any intervention. Questionnaires typically
took 30 min to complete. Patients did not receive any direction
regarding how they should be ﬁlled, but were provided stand-
ardised guidance notes and given the opportunity to ask questions.
Generic QoL measurement tools, such as the EuroQol (EQ-5D),
are divided into domains of interest. They thereby allow mental,
physical and social aspects of QoL to be evaluated independently.
Disease-speciﬁc QoL measurement tools, such as the AVVQ,8Table 1
An overview of the questionnaires used in this study.
Questionnaire Number
of items
Parameters evaluated
Aberdeen Varicose Vein
Questionnaire (AVVQ)
13 - Physical symptoms
- Compression therap
- Limitations of disea
EuroQoL-5D (EQ-5D) 5 - Mobility
- Self-care
- Pain/Discomfort
- Anxiety/Depression
EuroQoL-Visual Analogue
Score (EQ-VAS)
n/a This is a 20 cm subje
to health-related qua
Centre of Epidemiological
Studies Depression Score (CES-D)
20 This is a sensitive and
depression-symptom
Clinical Stage of the Clinical Etiologic
Anatomic Pathophysiologic
(CEAP) Classiﬁcation
6 C0 e no visible varico
C1 e spider or reticu
2 e Varicose veins
3 e Oedema
4 e Skin changes
5 e Healed ulcer
6 e Active ulcer
Venous Clinical Severity Score (VCSS) 9 Evaluates for presenc
inﬂammation and ind
of compression hosie
Venous Disability Score (VDS) 1 Based on the ability t
the requirement for eattempt to quantify the change in QoL due to an individual
disease state. In combination, these two types of tool provide
a powerful and robust method for assessing both the baseline QoL
and disease-speciﬁc QoL and were therefore both utilised in this
study.
Patient age, occupation, gender, medical co-morbidity and
history of previous intervention for varicose veins were also
determined. The clinical severity of venous disease was established
by the treating physician using the Clinical Etiologic Anatomic
Pathophysiologic (CEAP) classiﬁcation, Venous Clinical Severity
Score (VCSS) and Venous Disability Score (VDS).12
Once completed, all questionnaires were collated and analysed.
The number of eligible patients who did not complete the ques-
tionnaire was also recorded. Patients with CES-D scores of >16
were referred to their GP for further management.
Statistical analysis
Univariate linear correlation analysis was used to assess the
relationship between two independent variables. Mann-Whitney-
U test was used to assess the difference between two indepen-
dent groups. Statistical signiﬁcance was expressed as both p values
and 95% conﬁdence intervals. A p value <0.05 was considered
statistically signiﬁcant.
Results
Demographic data
A hundred patients were recruited from a total of 125 eligible
patients (80% uptake) over the 6 months study period. There were
37 men (37%) and 63 women (63%). All questionnaires were fully
completed and included in the analysis. The mean age of patients
was 52.7 years (range, 24e91 years), 72% of patients were under the
age of 65 and 28% were aged 65 years or more. There was no
signiﬁcant correlation between CES-D score and patient age
(p ¼ 0.30, r2 ¼ 0.011). There was no difference in depression scoresScore
y use
se on daily and social activities
0 (no effect) to 100 (severe effect)
n/a
ctive visual analogue scale relating
lity of life
100-0
validated self-reporting
scale
0e60
>16 suggests depression
>26 suggests severe depression
se veins
lar veins
0e6
e of skin changes and pigmentation,
uration, presence of ulcers and use
ry
Maximum score of 27
o work an 8-h day with or without
xternal compression hosiery support
0e3
Figure 2. Graph demonstrating a correlation between CES-D and health-related
quality of life as indicated by the EQ-5D (p < 0001, r2 ¼ 0.32) and EQ-VAS scores
(p ¼ 0.0009, r2 ¼ 0.25).
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65 years old (p ¼ 0.60).
Twenty-nine per cent of all patients had CES-D scores greater
than 16 and 5% of patients had CES-D scores greater than 26. No
patient had previously been diagnosed or treated, or were on
current treatment for depression.
In terms of past medical history, no patient had co-existing
peripheral vascular disease. Thirty-three patients (33%) had previ-
ously undergone intervention for their varicose veins. There was no
signiﬁcant difference in CES-D scores in patients who had previ-
ously undergone treatment for their varicose veins, compared to
those who had not (p ¼ 0.94).
Depression and quality of life
A weak positive correlation was seen between CES-D score and
disease-speciﬁc QoL as evaluated using the AVVQ (p ¼ 0.0009,
r2 ¼ 0.11) (see Fig. 1). A signiﬁcant negative correlation was seen
between CES-D score and health-related QoL as indicated by EQ-5D
(p < 0.0009, r2 ¼ 0.32) and EQ-VAS scores (p < 0.0009, r2 ¼ 0.25)
(see Figs. 2 and 3). Higher EQ-5D and EQ-VAS, unlike the AVVQ
score, indicate better QoL and lower EQ-5D and EQ-VAS scores
worse QoL.
Depression and clinical severity of venous disease
Patients with severe depression (n ¼ 5) were observed to have
venous disease of clinical stage 4e6, as deﬁned by the CEAP classi-
ﬁcation. However, overall there was no difference in CES-D scores
with varying clinical stage (p ¼ 0.30). CES-D score did not correlate
with theVCSS (p¼0.07, r2¼0.03)orVDS (p¼0.75) (see Figs. 4 and5).
Discussion
The presence of depression in patients with varicose veins has
undergone only limited investigation previously. In contrast, QoL
status in patients with varicose veins has been extensively inves-
tigated,8,13e15 and is an accepted outcome measure used both in
clinical practice and in clinical trials investigating varicose vein
treatment.5,16,17 QoL measures are also shown to be better corre-
lated with symptomatology and patient satisfaction than anatom-
ical or technical measures.18
Varicose veins are common with a reported incidence of
20e25% in women, and 10e15% in men.19,20 A number of studies
have shown an increased incidence of depression and anxiety in
patients with venous ulcers, with reported incidences ranging from
40 to 60%.21e23 Our study reports an incidence of depression in
patients with symptomatic varicose veins of 29% and this falls toFigure 1. Graph demonstrating a positive correlation between CES-D and disease
speciﬁc quality of life as indicated by the AVVQ score (p ¼ 0.0009, r2 ¼ 0.11).26% when patients with healed or active venous ulcers are
excluded. This is twice the reported prevalence of depression
within the general population,24 but is similar to that reported in
patients with chronic physical health problems.
Esteban et al, in a Spanish study of 7341 subjects aged>15 years
with a variety of chronic medical diseases, found that depression
had a signiﬁcant impact on health-related QoL.25 When looking
speciﬁcally at the impact of venous disease onmental health, Smith
et al in their study found no signiﬁcant difference in the mental
health domain of the SF-36 in patients with varicose veins
compared to those without,4 but following treatment with open
surgery there was a signiﬁcant improvement in the mental health
domain. In our study, depressive symptoms correlated with
disease-speciﬁc and health-related QoL outcomes, however, we
failed to demonstrate any correlation with clinical disease severity.
A possible explanation is that depression may alter a patient’s
perception of the severity of venous disease. Chronic physical
health problems are also seen to precipitate and exacerbate
depression and this may be true for varicose veins.26
In our study similar depression scores were reported amongst
men and women. This is in contrast to the incidence within the
general population, where women are twice as likely to suffer from
depression compared to men.27 The reasons for this are unclear. In
addition, there was no correlation with depression and age as
documented in other studies of depression in the general pop-
ulation. However, there were few patients in our study over the age
of 65 years (27%).
Both depression and varicose veins are treatable once diag-
nosed. Work by Chassany et al28 showed that general practitionersFigure 3. Graph demonstrating a correlation between CES-D and health-related
quality of life as indicated by the EQ-5D (p < 0001, r2 ¼ 0.32) and EQ-VAS scores
(p ¼ 0.0009, r2 ¼ 0.25).
Figure 4. Graph demonstrating Venous Clinical Severity Score (VCS) and Venous
Disability Score (VDS) in relation to CES-D score. No difference in CES-D scores is seen
with VCCS (p ¼ 0.07, r2 ¼ 0.03) or VDS (p ¼ 0.75).
Figure 5. Graph demonstrating Venous Clinical Severity Score (VCS) and Venous
Disability Score (VDS) in relation to CES-D score. No difference in CES-D scores is seen
with VCCS (p ¼ 0.07, r2 ¼ 0.03) or VDS (p ¼ 0.75).
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venous disease whilst over-estimating that from peripheral arterial
occlusive disease. Notably, no patients in our study had previously
been diagnosed or were on treatment for their depression.
The aim of this study was to assess the burden of disease in
ambulatory patients with symptomatic varicose veins, who have
presented to their GP and subsequently to a vascular surgeon for
treatment. However, this group of patients may not reﬂect the
burden of depression in varicose veins patients within the general
population. Moreover, the inﬂuence of socioeconomic factors and
ethnicity on depression scores was not ascertained in this study.
Further information regarding depression scores following venous
intervention will be useful in establishing whether the symptoms
of depression are reversible following intervention and hence
would enhance our understanding of the problems these patients
face. This is part of on-going work by our group.
Conclusion
Patients with symptomatic varicose veins are at increased risk of
depression compared to the general population. This study reports
a high incidence of previously unreported and undiagnosed
depression in this group of patients. Further investigation of
a patient’s wellbeing and a more holistic approach in the
management of patients with venous disease is therefore
recommended.
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